clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Ultra-Low Energy MRI Shows Its Potential
News & Features
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Informatics
DeepMind’s Next-Gen Protein Structure Predictor AlphaFold 3 Released
News & Features
AI Improves Prostate Cancer Recurrence Prediction
News & Features
Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Finding the Needle in the Haystack with Synthetic DNA
DNA biology
Molecular Dx
Finding the Needle in the Haystack with Synthetic DNA
Chris Anderson
-
October 2, 2020
0
Molecular Dx
New Insight into DNA Synthesis Could Lead to Novel Anti-Cancer Drugs
Malorye Branca
-
March 2, 2020
0
News & Features
New Drug Could Improve Response to Chemotherapy
Malorye Branca
-
June 6, 2019
0
News & Features
Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor
Malorye Branca
-
June 3, 2019
0
News & Features
Five-Year Super Successes in Genomics and Precision Medicine
Alex Philippidis
-
March 27, 2019
0
Molecular Dx
Vaping Tied to DNA Damage
Inside Precision Medicine Staff Writer
-
August 20, 2018
0
Molecular Dx
DNA as Malware: Biohackers Use Synthetic DNA to Hijack Computer Function
Meghaan Ferreira, Ph.D.
-
October 2, 2017
0
Informatics
Malware Could be Delivered to Sequencing Systems via Synthetic DNA
Inside Precision Medicine Staff Writer
-
August 10, 2017
0
News & Features
96-Well Comet Chip for DNA Damage Measurement
Inside Precision Medicine Staff Writer
-
June 1, 2016
0
News & Features
p53 Maintains Genomic Stability through Transposon Restraint
Inside Precision Medicine Staff Writer
-
January 25, 2016
0
1
2
3
Page 3 of 3
Related Content
Patients of New Doctors with High Board Certification Scores Have Higher Survival Rates
Patient Adverse Events Prevalent in Outpatient Settings
Healthy Lifestyle Reduces Genetic Risk of Dying Early
Pandemic Preparedness Needs Genomic Surveillance
Inside Precision Medicine
![A three-protein biomarker panel has been established that is able to screen urine samples for signs of early-stage pancreatic cancer. [iStock/© David Marchal]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/289.jpeg "Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor")
